Ramadan, W.S.; Vazhappilly, C.G.; Saleh, E.M.; Menon, V.; AlAzawi, A.M.; El-Serafi, A.T.; Mansour, W.; El-Awady, R.
Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy. Cancers 2019, 11, 13.
https://doi.org/10.3390/cancers11010013
AMA Style
Ramadan WS, Vazhappilly CG, Saleh EM, Menon V, AlAzawi AM, El-Serafi AT, Mansour W, El-Awady R.
Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy. Cancers. 2019; 11(1):13.
https://doi.org/10.3390/cancers11010013
Chicago/Turabian Style
Ramadan, Wafaa S, Cijo George Vazhappilly, Ekram M Saleh, Varsha Menon, Aya M AlAzawi, Ahmed T El-Serafi, Wael Mansour, and Raafat El-Awady.
2019. "Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy" Cancers 11, no. 1: 13.
https://doi.org/10.3390/cancers11010013
APA Style
Ramadan, W. S., Vazhappilly, C. G., Saleh, E. M., Menon, V., AlAzawi, A. M., El-Serafi, A. T., Mansour, W., & El-Awady, R.
(2019). Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy. Cancers, 11(1), 13.
https://doi.org/10.3390/cancers11010013